RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
KORU Medical Systems Stock

KORU Medical Systems Revenue 2025

KORU Medical Systems Revenue

40.74 M USD

Ticker

KRMD

ISIN

US7599101026

WKN

913004

In 2025, KORU Medical Systems's sales reached 40.74 M USD, a 21.08% difference from the 33.65 M USD sales recorded in the previous year.

The KORU Medical Systems Revenue history

YEARREVENUE (M USD)GROSS MARGIN (%)
2027e54.0639,46
2026e47.4145,00
2025e40.7452,36
202433.6563,40
202328.5258,59
202227.955,09
202123.4958,62
202024.1861,79
201923.1664,12
201817.3562,31
201713.3161,16
201612.2961,59
201512.2562,04
201411.2459,52
20138.761,03
20127.7663,66
20116.3964,79
20104.9266,26
20093.7766,58
20083.4463,95
20072.3561,70
20061.7461,49
20051.7558,29

KORU Medical Systems Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into KORU Medical Systems, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by KORU Medical Systems from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects KORU Medical Systems’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of KORU Medical Systems. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into KORU Medical Systems’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing KORU Medical Systems’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on KORU Medical Systems’s growth potential.

KORU Medical Systems Revenue, EBIT and net profit per share

DateKORU Medical Systems RevenueKORU Medical Systems EBITKORU Medical Systems Net Income
2027e54.06 M undefined1.03 M undefined934,375.1 undefined
2026e47.41 M undefined-1.41 M undefined-1.12 M undefined
2025e40.74 M undefined-4.26 M undefined-3.74 M undefined
202433.65 M undefined-6.45 M undefined-6.07 M undefined
202328.52 M undefined-10.27 M undefined-13.74 M undefined
202227.9 M undefined-10.78 M undefined-8.66 M undefined
202123.49 M undefined-7.03 M undefined-4.56 M undefined
202024.18 M undefined1.2 M undefined-1.21 M undefined
201923.16 M undefined4.01 M undefined560,000 undefined
201817.35 M undefined1.16 M undefined910,000 undefined
201713.31 M undefined1.24 M undefined900,000 undefined
201612.29 M undefined-740,000 undefined-540,000 undefined
201512.25 M undefined1.18 M undefined780,000 undefined
201411.24 M undefined1.15 M undefined750,000 undefined
20138.7 M undefined1.01 M undefined700,000 undefined
20127.76 M undefined1.06 M undefined730,000 undefined
20116.39 M undefined1.29 M undefined820,000 undefined
20104.92 M undefined1.19 M undefined700,000 undefined
20093.77 M undefined720,000 undefined880,000 undefined
20083.44 M undefined780,000 undefined1.02 M undefined
20072.35 M undefined190,000 undefined-10,000 undefined
20061.74 M undefined-20,000 undefined-260,000 undefined
20051.75 M undefined-180,000 undefined-230,000 undefined

KORU Medical Systems stock margins

The KORU Medical Systems margin analysis displays the gross margin, EBIT margin, as well as the profit margin of KORU Medical Systems. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for KORU Medical Systems.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the KORU Medical Systems's sales revenue. A higher gross margin percentage indicates that the KORU Medical Systems retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the KORU Medical Systems's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the KORU Medical Systems's total revenue generated. When comparing the revenue margin year over year, investors can gauge the KORU Medical Systems's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the KORU Medical Systems. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the KORU Medical Systems's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

KORU Medical Systems Margin History

KORU Medical Systems Gross marginKORU Medical Systems Profit marginKORU Medical Systems EBIT marginKORU Medical Systems Profit margin
2027e63.4 %1.91 %1.73 %
2026e63.4 %-2.98 %-2.37 %
2025e63.4 %-10.45 %-9.17 %
202463.4 %-19.16 %-18.03 %
202358.59 %-36.01 %-48.18 %
202255.09 %-38.64 %-31.04 %
202158.62 %-29.93 %-19.41 %
202061.79 %4.96 %-5 %
201964.12 %17.31 %2.42 %
201862.31 %6.69 %5.24 %
201761.16 %9.32 %6.76 %
201661.59 %-6.02 %-4.39 %
201562.04 %9.63 %6.37 %
201459.52 %10.23 %6.67 %
201361.03 %11.61 %8.05 %
201263.66 %13.66 %9.41 %
201164.79 %20.19 %12.83 %
201066.26 %24.19 %14.23 %
200966.58 %19.1 %23.34 %
200863.95 %22.67 %29.65 %
200761.7 %8.09 %-0.43 %
200661.49 %-1.15 %-14.94 %
200558.29 %-10.29 %-13.14 %

KORU Medical Systems Aktienanalyse

What does KORU Medical Systems do?

Repro Med Systems Inc is a US-based company specializing in the development and manufacturing of medical devices for infusion therapy. The company was founded in 1980 by Edward L. Swanson and is headquartered in Chester, New York. Repro Med Systems Inc started as a small family business developing medical devices for reproductive medicine. Over the years, the company expanded and began focusing on other medical applications. In the 1990s, the company developed an innovative infusion pump system, later known as the "Freedom Syringe Infusion System." This system received numerous patents and proved to be a groundbreaking innovation in infusion therapy. Repro Med Systems Inc specializes in selling medical devices for infusion therapy. The company uses a direct sales model, allowing them to sell products directly to end customers. This enables the company to better understand customer needs and quickly respond to industry changes. Repro Med Systems Inc offers a variety of products for infusion therapy, including the "Freedom Syringe Infusion System," the "MRidium" infusion pump system, and the "Freo" intermittent dosing infusion pump system. The "Freedom Syringe Infusion System" is a portable infusion pump system that allows the administration of medications and fluids through a needleless disposable syringe. The system is easier to use than conventional infusion pumps and provides patients with more freedom and mobility during treatment. The "MRidium" infusion pump system has been specifically designed for use in magnetic resonance imaging (MRI). The system is immune to magnetic interference and can be used during an MRI examination to provide patients with infusions. The "Freo" intermittent dosing infusion pump system is a simple and reliable system that allows the administration of medications in variable doses. The system is ideal for pain management and enables patients to administer their medications quickly and easily. In conclusion, Repro Med Systems Inc is an innovative company specializing in the development and manufacturing of medical devices for infusion therapy. The company has experienced remarkable growth in recent years and is now a key player in the industry. With its focus on innovation and customer satisfaction, the company is expected to continue to be successful in the future. KORU Medical Systems ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding KORU Medical Systems's Sales Figures

The sales figures of KORU Medical Systems originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing KORU Medical Systems’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize KORU Medical Systems's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in KORU Medical Systems’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about KORU Medical Systems stock

How much revenue did KORU Medical Systems generate this year?

KORU Medical Systems has achieved a revenue of 40.74 M USD this year.

How much was the turnover of the company KORU Medical Systems compared to the previous year?

The revenue of KORU Medical Systems has increased by 21.08% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of KORU Medical Systems?

The revenue of KORU Medical Systems is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of KORU Medical Systems measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of KORU Medical Systems so important for investors?

The revenue of KORU Medical Systems is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does KORU Medical Systems pay?

Over the past 12 months, KORU Medical Systems paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, KORU Medical Systems is expected to pay a dividend of 0 USD.

What is the dividend yield of KORU Medical Systems?

The current dividend yield of KORU Medical Systems is .

When does KORU Medical Systems pay dividends?

KORU Medical Systems pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of KORU Medical Systems?

KORU Medical Systems paid dividends every year for the past 0 years.

What is the dividend of KORU Medical Systems?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is KORU Medical Systems located?

KORU Medical Systems is assigned to the 'Health' sector.

Wann musste ich die Aktien von KORU Medical Systems kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of KORU Medical Systems from 10/20/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/20/2025.

When did KORU Medical Systems pay the last dividend?

The last dividend was paid out on 10/20/2025.

What was the dividend of KORU Medical Systems in the year 2024?

In the year 2024, KORU Medical Systems distributed 0 USD as dividends.

In which currency does KORU Medical Systems pay out the dividend?

The dividends of KORU Medical Systems are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von KORU Medical Systems

Our stock analysis for KORU Medical Systems Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of KORU Medical Systems Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.